## Abstract A small dose of the IgG~1~ fraction of anti‐idiotypic antibody (āId 1) raised in guinea pigs against a strain A/J antibody specific for streptococcal Group A carbohydrate sensitizes A/J mice against Group A streptococci. This is opposed to the previously established suppressive function
Induction and characterization of “autologous” anti-idiotypic antibodies
✍ Scribed by H. Cosenza; A. Augustin; M. H. Julius
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 625 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Upon immunization with phosphorylcholine (PC), conventional BALB/c mice produce anti‐PC antibodies bearing predominantly the idiotype characteristic of the BALB/c PC‐binding myeloma protein TEPC 15 (T1 5). To investigate whether BALB/c mice are able to produce antibodies to the autologous T15 idiotype, conventional (T1 5‐positive) and neonatally suppressed (T1 5‐negative) BALB/c mice were immunized with purified T15 myeloma protein. Both groups of mice produced IgG antibodies specific for the T1 5 idiotype. However, anti‐T 15 antibodies were more readily induced in neonatally suppressed mice which in turn produced higher anti‐T15 titers than conventional mice. Such “autologous” anti‐T 15 antibodies are able to (a) change the idiotypic pattern of the anti‐PC response of conventional BALB/c mice in situ and, (b) inhibit the induction of an anti‐PC response in vitro by spleen cells from T15‐positive but not T15‐negative BALB/c mice. Thus, BALB/c mice are capable of producing anti‐T 15 antibodies upon immunization with an isologous myeloma protein which bears the autologous T1 5 idiotype. We suggest that idiotypes should not be strictly considered as “self‐antigens” since the dramatic increase in their concentration, subsequent to antigen stimulation, might confer upon them immunogenic properties not shared by self‐antigens.
📜 SIMILAR VOLUMES
Disialoganglioside GD2 is widely expressed among neuroblastomas, melanomas, small-cell lung carcinoma, sarcomas and brain tumors. Immunity directed against this antigen may have anti-tumor utility. Since GDz is poorly immunogenic, antiidiotypic antibodies may serve as alternative tumor vaccines. Mon
anticytokeratin monoclonal antibody (TS1) and a nonlabeled antiidiotypic monoclonal antibody against TS1 (aTS1) were compared with a single injection of the Per Sandstro ¨m, B.Sc. 2 Daniel Holback, B
Rabbit anti-rat anti-human thyrotropin anti-idiotypic antibodies have been raised. These antibodies were active at the thyrotropin (TSH) receptor, in that they inhibited 125I-labeled bovine TSH binding to thyroid plasma membranes, stimulated adenylate cyclase activity through a guanyl nucleotide-dep